Preview Mode Links will not work in preview mode

This Week in Cardiology

Apr 15, 2022

ACC Recap, Part 2: VT ablation, HF care, three-vessel disease, and patiromer are the topics John Mandrola, MD, covers in this week’s podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I – VT ablation

VT Ablation After First ICD Shock Boosts Survival: PARTITA

Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial

Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia

Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs

II – HF Care

Alerts Improve Prescribing of HF Quadruple Therapy: PROMPT-HF

Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial

Reassessing Quality Assessment — The Flawed System for Fixing a Flawed System

III – Three-Vessel Disease

FAME 3 Subanalysis Adds Twist to Negative Primary Results

Fractional Flow Reserve–Guided PCI as Compared with Coronary Bypass Surgery

Quality of Life After Fractional Flow Reserve-Guided PCI Compared with Coronary Bypass Surgery

IV – Treating Drug Side Effects with More Drugs

DIAMOND: Adding Patiromer Helps Optimize HF Meds, Foils Hyperkalemia

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact